Journal article
An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009
S Lingaratnam, MA Slavin, L Mileshkin, B Solomon, K Burbury, JF Seymour, R Sharma, B Koczwara, SW Kirsa, ID Davis, M Prince, J Szer, C Underhill, O Morrissey, KA Thursky
Internal Medicine Journal | WILEY | Published : 2011
Abstract
Background: An abundance of new evidence regarding treatment strategies for neutropenic fever is likely to contribute to variability in practice across institutions and clinicians alike. Aims: To describe current clinical practices in Australia, by surveying haematologists, oncologists and infectious diseases physicians involved in cancer care. Methods: Clinician members from Australian professional associations, accounting for the vast majority of Australian cancer specialists, were invited to participate in an electronic survey, comprising of a clinical case-based questionnaire. Clinical practice areas explored were: use of risk-assessment and empiric antibiotic strategies across various t..
View full abstractGrants
Funding Acknowledgements
Conflict of interest: The following working group members are consultants or advisory committee members or receive honoraria, fees for service, or travel assistance (independent of research-related meetings) from; or have research or other associations with the organisations listed: Ian Davis - Novartis, Pfizer, GlaxoSmithKline, Schering-Plough; Sue Kirsa - Roche, Schering Plough, Amgen, Hospira, Alphapharm; Senthil Lingaratnam - Victorian Integrated Cancer Services; Orla Morrissey - Gilead, Merck Sharp & Dohme, Orphan, Pfizer, Schering Plough; Monica Slavin - Gilead, Merck Sharp & Dohme, Pfizer, Schering Plough; Karin Thursky - Gilead, Merck Sharp & Dohme, Pfizer, Schering Plough.